DK0590150T3 - (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat - Google Patents

(-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Info

Publication number
DK0590150T3
DK0590150T3 DK92909279T DK92909279T DK0590150T3 DK 0590150 T3 DK0590150 T3 DK 0590150T3 DK 92909279 T DK92909279 T DK 92909279T DK 92909279 T DK92909279 T DK 92909279T DK 0590150 T3 DK0590150 T3 DK 0590150T3
Authority
DK
Denmark
Prior art keywords
azaspiro
oxa
decane
tartrate
methylene
Prior art date
Application number
DK92909279T
Other languages
Danish (da)
English (en)
Inventor
Shin-Ichi - - Kasuga Tsukamoto
Takeru Sumitomojuutak Kohinata
Mitsuo - Kanbeeshinden I Fujii
Sakiko - Asahigaokama Tomizawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of DK0590150T3 publication Critical patent/DK0590150T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92909279T 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat DK0590150T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13961991 1991-05-15
PCT/JP1992/000548 WO1992020683A1 (fr) 1991-05-15 1992-04-27 L-tartrate de (-)-(s)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decane

Publications (1)

Publication Number Publication Date
DK0590150T3 true DK0590150T3 (da) 1999-04-19

Family

ID=15249510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909279T DK0590150T3 (da) 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Country Status (11)

Country Link
US (1) US5403931A (fr)
EP (1) EP0590150B1 (fr)
AT (1) ATE168114T1 (fr)
AU (1) AU1666392A (fr)
CA (1) CA2109117A1 (fr)
DE (1) DE69226187T2 (fr)
DK (1) DK0590150T3 (fr)
ES (1) ES2118814T3 (fr)
GR (1) GR3027686T3 (fr)
RU (1) RU2057132C1 (fr)
WO (1) WO1992020683A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU684828B2 (en) * 1993-08-19 1998-01-08 Merck Sharp & Dohme Corp. Thermodynamically stable crystal form of 4"-deoxy-4"-(epi)-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
WO1999049870A1 (fr) * 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamine d et ses analogues pour le traitement de tumeurs et d'autres troubles d'hyperproliferation
JP2003063964A (ja) * 2001-08-28 2003-03-05 Senju Pharmaceut Co Ltd ドライアイまたはドライアイを伴なう疾病の予防治療剤
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
JPWO2007013661A1 (ja) * 2005-07-26 2009-02-12 千寿製薬株式会社 眼科用経皮吸収型製剤
EP1928437A2 (fr) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenese par modulation du recepteur muscarinique
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
CA2625153A1 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (fr) 2006-05-09 2012-02-29 Braincells, Inc. Neurogénèse par modulation d'angiotensine
WO2007134077A2 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenèse induite par le récepteur 5ht
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
NZ594768A (en) * 2009-01-26 2013-02-22 Israel Inst Biolog Res Bicyclic heterocyclic spiro compounds
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE122353T1 (de) * 1987-10-05 1995-05-15 Yamanouchi Pharma Co Ltd Heterozyklische spiroverbindungen und ihre herstellung.
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives

Also Published As

Publication number Publication date
DE69226187D1 (de) 1998-08-13
EP0590150A1 (fr) 1994-04-06
GR3027686T3 (en) 1998-11-30
DE69226187T2 (de) 1998-10-22
CA2109117A1 (fr) 1992-11-16
WO1992020683A1 (fr) 1992-11-26
RU2057132C1 (ru) 1996-03-27
ES2118814T3 (es) 1998-10-01
EP0590150A4 (en) 1994-06-29
US5403931A (en) 1995-04-04
AU1666392A (en) 1992-12-30
EP0590150B1 (fr) 1998-07-08
ATE168114T1 (de) 1998-07-15

Similar Documents

Publication Publication Date Title
DK0590150T3 (da) (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
FI942504A0 (fi) N,N'-diasetyylikystiinin orgaanisia suoloja
NO2002009I2 (no) Tiotropium
GR3020717T3 (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
DE69109021T2 (de) Augentropfenarzneimittel.
RU93058306A (ru) Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
ATE92759T1 (de) Carboplatinzusammensetzung.
DE69131163D1 (de) Asthma heilmittel
DE69400334D1 (de) Diaminsalze von clavulansäure
DE69033442D1 (de) Optisch aktive Verbindungen mit mehreren chiralen Zentren und ihre Herstellung
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
FR2649116B1 (fr) Composition organopolysiloxane monocomposante a stabilite au stockage amelioree
GR3031294T3 (en) Optically active 1,4-Dihydropyridine derivatives and methods of producing the same
ATE96025T1 (de) Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
ITVE910013A0 (it) Progetto di catamarano da competizione formula o.p.1. a stabilita' idrodinamica indotta
TW234715B (fr)